Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Dissecting This FMCG Giant – Colgate-Palmolive Company (CL): The Procter & Gamble Company (PG), Unilever N.V. (ADR) (UL)

Page 1 of 2

The recent devaluation of the Venezuelan currency, plus, an average fourth quarter aren’t good signs for Colgate-Palmolive Company (NYSE:CL). With strong competition from peers such as The Procter & Gamble Company (NYSE:PG) and Unilever N.V. (ADR) (NYSE:UL), the big question remains the same—what’s in store for the company in 2013?

Colgate-Palmolive Company (NYSE:CL)Devaluation of Venezuelan currency

Venezuela accounts for more than 5% of Colgate-Palmolive’s total revenue. Due to ongoing economic and labor issues in Venezuela, Colgate-Palmolive’s South American region hasn’t done that well lately. As a result of recent devaluation of Venezuelan Bolivar by 32%, Colgate-Palmolive Company (NYSE:CL) expects to report a one-time loss of $120 million, or $0.25 per share in 1Q13. The company’s earnings-per-share are estimated to fall by $0.05 to $0.07 in the quarter.

Quarterly earnings

In 4Q12, Colgate-Palmolive Company (NYSE:CL) reported earnings of $598 million or $1.26 per share, up from $590 million or $1.21 per share in the same quarter last year. Revenue grew 2.5% to $4.29 billion, missing analysts’ estimates of $4.31 billion. Prices were up 2.5%, while sales volume grew by 1.5%.

Organic sales grew by 4% in the recent quarter, compared to a growth of 5% and 8% in the third and second quarter respectively. Latin America, which constitutes about 29% of the company’s total sales, saw an organic sales growth of just 4% in the fourth quarter, compared to a 9% increase in the third and 14.5% increase in the fourth quarter of 2011. The chief reason behind this was a tough economic and labor environment in Venezuela, which had a negative effect on both sales and profits.

Forecast for 2013

In the next quarter, analysts expect Colgate-Palmolive to earn $1.32 per share on revenues of $4.3 billion. For the full year, the company is expected to earn $5.73 per share on $17.79 billion revenue.

Colgate-Palmolive Company (NYSE:CL) is trading at a forward P/E (1yr) of 18.25x, which shows that it’s an expensive buy in the fast-moving consumer goods (FMCG) sector. It has a PEG of 2.07 and a dividend yield of 2.20%. According to the sell side, it has a mean target price of $114, suggesting that it’s trading at its fair value and doesn’t have any upside potential at this stage. A mean recommendation of 2.8 on the sell side also shows that it isn’t an attractive buy.

Page 1 of 2
Loading Comments...